Candid Health, a San Francisco-based developer of autonomous revenue cycle management (RCM) technology, announced on Wednesday that it has successfully closed a $120 million Series D funding round. The investment was led by Sixth Street Growth, with significant participation from existing investors including Oak HC/FT, 8VC, and Y Combinator. This latest capital infusion comes less […]
The modern emergency department serves as the primary safety net for the American healthcare system, yet the metrics used to define its success are increasingly viewed as ill-suited for the growing volume of behavioral health crises. Two patients who present in the emergency department in identical ways can have very different treatment experiences, even if […]
The landscape of healthcare venture investing is undergoing a fundamental structural transformation, shifting from a model of reactive evaluation to one of proactive scientific discovery. For decades, the primary objective of healthcare investors was to identify the most promising startups within an established ecosystem. However, the coming decade is expected to favor a new breed […]
The rapid integration of artificial intelligence into the healthcare sector is forcing a fundamental reassessment of how identity is defined, verified, and managed. While the initial wave of AI adoption focused on improving clinical efficiency and diagnostic accuracy for providers, the industry is now approaching a critical juncture where AI agents will take on autonomous […]
The United States pharmaceutical landscape is currently defined by a stark and widening paradox: while scientific innovation is delivering groundbreaking cures at an unprecedented rate, the systems required to pay for and distribute these medicines are becoming increasingly fractured. Despite an annual national expenditure exceeding $800 billion on pharmaceuticals, a significant portion of the American […]
The landscape of digital health investment is undergoing a fundamental shift as venture capitalists move away from backing charismatic visionaries with "fix-it-all" mentalities toward founders who demonstrate deep self-awareness, operational discipline, and a willingness to pivot. During a featured panel discussion this week at MedCity News’ Bullseye event in Chicago, prominent investors from Town Hall […]
Priority Health, a prominent Michigan-based health insurer, has officially announced a strategic expansion of its employer-sponsored benefits through a new partnership with healthcare innovators Color Health and Grail. This collaboration, unveiled on Wednesday, introduces two distinct cancer support solutions designed to provide comprehensive care pathways and advanced early detection capabilities for large self-funded employers. Starting […]
Scribe Therapeutics, a biotechnology firm specializing in the engineering of novel genetic medicines, has officially entered the public markets, securing $128.7 million in an upsized initial public offering (IPO). The Alameda, California-based company, co-founded by Nobel laureate Jennifer Doudna, aims to transition genetic medicine from its current focus on rare, niche disorders toward prevalent chronic […]
The healthcare industry is currently navigating a technological transformation that differs fundamentally from previous cycles of innovation, such as the dot-com era or the initial breakthroughs in genomic sequencing. During a high-level panel discussion at the MedCity News Bullseye event in Chicago, leading venture capitalists and healthcare executives argued that artificial intelligence (AI) has crossed […]
The current state of the United States healthcare system is frequently characterized by its inefficiencies, ranging from a stubborn reliance on legacy technologies like fax machines to a complex web of perverse financial incentives that often prioritize volume over value. During the MedCity News Bullseye event held in Chicago, a rare moment of industry self-reflection […]
